Episode Details

Our latest discussion highlights the critical role of seed oils in cancer progression, using a stage three colon cancer patient as a case study.

Despite standard cancer treatment, her cancer showed recurrence, prompting a deeper look into her metabolic health and gut health. We explore how factors like inflammation in the body and a dysbiotic gut microbiome can significantly influence patient outcomes, emphasizing the need for a holistic approach to nutrition and healthy eating.

🎯 What You’ll Learn in This Episode

• The difference between seed oils and oxidized fats
• What lipid peroxidation means
• How cooking methods affect oil stability
• Why heat, light, and storage matter
• The connection between gut health and immunity
• How inflammation impacts the body
• Which fats are more stable for cooking
• Practical ways to reduce oxidative stress in your diet

📍 Envita Medical Centers – Scottsdale, AZ
🌐 Learn more: www.envita.com
📞 Speak with a care coordinator: 866-830-4576

“It’s not just what you eat — it’s how it’s processed, stored, and cooked.”

Disclaimer
This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.
________________________________________
Outcomes Disclaimer
The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.

You can read the full peer-reviewed study at: 

https://www.scirp.org/journal/paperinformation?paperid=132493